Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by ...
Pharmaceutical Technology on MSN
CSL to pump $1.5bn into US plasma supply chain
CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.
A little over five years ago, the Trump administration announced Operation Warp Speed to deliver a vaccine for COVID-19. It was one of the most stunning successes of Trump’s first term. Recognizing a ...
Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results